Germany
· Delayed Price · Currency is EUR UnitedHealth Group Statistics
Total Valuation
UnitedHealth Group has a market cap or net worth of EUR 455.85 billion. The enterprise value is 506.49 billion.
| Market Cap | 455.85B |
| Enterprise Value | 506.49B |
Important Dates
The last earnings date was Friday, January 10, 2025.
| Earnings Date | Jan 10, 2025 |
| Ex-Dividend Date | Dec 9, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.96% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 917.84M |
Valuation Ratios
The trailing PE ratio is 32.76.
| PE Ratio | 32.76 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.33, with an EV/FCF ratio of 25.33.
| EV / Earnings | 36.40 |
| EV / Sales | 1.30 |
| EV / EBITDA | 14.33 |
| EV / EBIT | 16.14 |
| EV / FCF | 25.33 |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.75.
| Current Ratio | 0.83 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | 3.71 |
| Interest Coverage | 8.27 |
Financial Efficiency
Return on equity (ROE) is 15.13% and return on invested capital (ROIC) is 11.67%.
| Return on Equity (ROE) | 15.13% |
| Return on Assets (ROA) | 7.06% |
| Return on Capital (ROIC) | 11.67% |
| Revenue Per Employee | 878,701 |
| Profits Per Employee | 31,622 |
| Employee Count | 440,000 |
| Asset Turnover | 1.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.50% in the last 52 weeks. The beta is 0.59, so UnitedHealth Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +4.50% |
| 50-Day Moving Average | 532.21 |
| 200-Day Moving Average | 503.56 |
| Relative Strength Index (RSI) | 39.31 |
| Average Volume (20 Days) | 695 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, UnitedHealth Group had revenue of EUR 386.63 billion and earned 13.91 billion in profits. Earnings per share was 14.98.
| Revenue | 386.63B |
| Gross Profit | 86.35B |
| Operating Income | 31.19B |
| Pretax Income | 19.39B |
| Net Income | 13.91B |
| EBITDA | 35.15B |
| EBIT | 31.19B |
| Earnings Per Share (EPS) | 14.98 |
Balance Sheet
The company has 28.12 billion in cash and 74.28 billion in debt, giving a net cash position of -49.83 billion.
| Cash & Cash Equivalents | 28.12B |
| Total Debt | 74.28B |
| Net Cash | -49.83B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 99.09B |
| Book Value Per Share | 102.39 |
| Working Capital | -17.38B |
Cash Flow
In the last 12 months, operating cash flow was 23.38 billion and capital expenditures -3.38 billion, giving a free cash flow of 20.00 billion.
| Operating Cash Flow | 23.38B |
| Capital Expenditures | -3.38B |
| Free Cash Flow | 20.00B |
| FCF Per Share | n/a |
Margins
Gross margin is 22.33%, with operating and profit margins of 8.07% and 3.60%.
| Gross Margin | 22.33% |
| Operating Margin | 8.07% |
| Pretax Margin | 5.01% |
| Profit Margin | 3.60% |
| EBITDA Margin | 9.09% |
| EBIT Margin | 8.07% |
| FCF Margin | 5.17% |
Dividends & Yields
This stock pays an annual dividend of 7.56, which amounts to a dividend yield of 1.53%.
| Dividend Per Share | 7.56 |
| Dividend Yield | 1.53% |
| Dividend Growth (YoY) | 11.69% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 52.29% |
| Buyback Yield | 0.96% |
| Shareholder Yield | 2.49% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |